piracetam has been researched along with Bile Duct Obstruction in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 44-year-old white woman with primary progressive MS receiving a multidrug of PO baclofen 75 mg/d, PO piracetam 3 g/d, and IV mitoxantrone 10 mg administered once a month presented to the Multiple Sclerosis Center, University of Catania, Catania, Italy." | 3.75 | Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis. ( Caruso, A; Neri, S; Patti, F; Vecchio, R, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caruso, A | 1 |
| Vecchio, R | 1 |
| Patti, F | 1 |
| Neri, S | 1 |
1 other study available for piracetam and Bile Duct Obstruction
| Article | Year |
|---|---|
Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis.
Topics: Administration, Oral; Adult; Baclofen; Biopsy; Chemical and Drug Induced Liver Injury; Cholestasis; | 2009 |